Key facts
- Veragrow’s last known valuation is $4.2M (Nov 2023).
- It has raised $6.5M; the latest was Later Stage VC ($5.2M) in Dec 2025.
- Notable investors include Bpifrance, Odyssee Venture, Altarence, Beauvais Technova, Credit Agricole Innove — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Veragrow
- ·The full record, as it builds
Funding rounds
No funding rounds for Veragrow are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Veragrow
Developer of a biological crop-enhancement formulation designed for improving plant growth, soil quality, and crop resilience through compounds extracted from vermicompost. The company uses processed worm-derived organic material, concentrated bioactive components, and tailored formulations for agricultural, turf, and garden use, enabling growers to enhance plant vigor and soil fertility with naturally sourced inputs.
- Sector
- Materials and Resources
- HQ
- Rouen, France
- Founded
- 2018
- Employees
- 19
- Website
- veragrow.com/
- Ownership
- Privately Held (backing)
Veragrow doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Veragrow shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Veragrow in its N-PORT filings yet. We sweep new filings monthly.